Prostate cancer survival is dependent on season of diagnosis

被引:43
作者
Lagunova, Zoya [1 ]
Porojnicu, Alina Carmen
Dahlback, Arne
Berg, Jens Petter
Beer, Tomasz M.
Moan, Johan
机构
[1] Inst Canc Res, Dept Radiat Biol, Oslo, Norway
[2] Univ Oslo, Dept Phys, Oslo, Norway
[3] Aker Univ Hosp, Hormone Lab, Oslo, Norway
[4] Univ Oslo, Aker Univ Hosp, Fac Div, Oslo, Norway
[5] Oregon Hlth & Sci Univ, Dept Med, Div Haematol & Med Oncol, Portland, OR 97201 USA
关键词
prostate cancer; vitamin D; seasonal variation; prognosis; latitude dependency;
D O I
10.1002/pros.20577
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. We have earlier found that the prognosis for several cancers is dependent on season of diagnosis. More recently, both prostate cancer incidence and mortality have been shown to increase with increasing latitude, which probably relates to photosynthesis of vitamin D. METHODS. The 3 year survival of prostate cancer patients has been analyzed with the Cox regression method for two age groups at different latitudes in Norway. RESULTS. Patients diagnosed during the summer and autumn had the best prognosis (Ralative risk (RR) death 0.8; 95% CI 0.75-0.85). Similar results were observed in three regions of the country that differ with respect to annual fluences of solar UV radiation, incidence rates of squamous cell carcinoma (SCC) and intake of fish. Furthermore, similar relationship between the season and survival was seen among patients <=65 years and >65 years old, although the younger group had a slightly larger advantage of summer and autumn diagnosis. CONCLUSIONS. The seasonal effect on prognosis may be related to the seasonal variations of calcidiol (the marker of vitamin D status). The lack of latitude effect and the similarity of prognosis for different age groups may be related to higher consumption of vitamin D in food in the north region and to increase of such consumption with age.
引用
收藏
页码:1362 / 1370
页数:9
相关论文
共 66 条
[1]   VITAMIN-D SYNTHESIS AND METABOLISM AFTER ULTRAVIOLET-IRRADIATION OF NORMAL AND VITAMIN-D-DEFICIENT SUBJECTS [J].
ADAMS, JS ;
CLEMENS, TL ;
PARRISH, JA ;
HOLICK, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (12) :722-725
[2]  
[Anonymous], AM J HLTH STUD
[3]  
[Anonymous], STAT NORWAY
[4]   1α, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis [J].
Bao, Bo-Ying ;
Yao, Jorge ;
Lee, Yi-Fen .
CARCINOGENESIS, 2006, 27 (09) :1883-1893
[5]   1α,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases [J].
Bao, BY ;
Yeh, SD ;
Lee, YF .
CARCINOGENESIS, 2006, 27 (01) :32-42
[7]   Rationale for the development and current status of calcitriol in androgen-independent prostate cancer [J].
Beer, TM ;
Myrthue, A ;
Eilers, KM .
WORLD JOURNAL OF UROLOGY, 2005, 23 (01) :28-32
[8]  
Beer TM, 2004, MOL CANCER THER, V3, P373
[9]   Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer [J].
Beer, Tomasz M. ;
Javle, Milind M. ;
Ryan, Christopher W. ;
Garzotto, Mark ;
Lam, Gilbert N. ;
Wong, Alvin ;
Henner, W. David ;
Johnson, Candace S. ;
Trump, Donald L. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (05) :581-587
[10]   Associations between prostate cancer susceptibility and parameters of exposure to ultraviolet radiation [J].
Bodiwala, D ;
Luscombe, CJ ;
French, ME ;
Liu, S ;
Saxby, MF ;
Jones, PW ;
Fryer, AA ;
Strange, RC .
CANCER LETTERS, 2003, 200 (02) :141-148